Received May 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | MM0513 | IM / RA |
Summary of Adverse Event: The patient reports that immediately upon administration of the Prevnar-20 vaccine on April 27, she experienced severe, deep pain at the injection site in the right shoulder. She describes the pain as intense and significantly beyond expected post-injection discomfort. Within approximately two hours of vaccination, the patient developed marked functional impairment of the right upper extremity. She reports inability to lift her right arm, significant loss of strength, and severe shoulder pain. Notably, the patient denies any prior history of right shoulder pain or dysfunction before this vaccination. Due to ongoing symptoms, the patient sought evaluation on May 6 at Urgent Care, where she was assessed by Dr. Imaging with X-rays demonstrated significant swelling in the region of the rotator cuff, along with clinically notable reduction in right shoulder strength on examination. The evaluating provider expressed concern for subacromial bursitis and initiated treatment with an oral corticosteroid regimen (Medrol Dosepak). Additionally, there was concern for potential early development of adhesive capsulitis. To mitigate stiffness and preserve function, the patient was started on physical therapy. Follow-Up Plan: The patient will follow up with orthopedics in approximately six weeks for reassessment. If symptoms of weakness or stiffness persist, further evaluation with MRI may be considered. Impact on Patient: The patient reports ongoing pain and functional limitation. She has missed work as a result of these symptoms, leading to loss of income and continued distress related to her condition.
Eosinophilic esophagitis, Cervical radiculitis, Cervical spine arthritis, DDD (degenerative disc disease), cervical, High cholesterol, OCD (obsessive compulsive disorder), PTSD (post-traumatic stress disorder), Spinal stenosis, Surgical menopause on hormone replacement therapy, Elevated lipoprotein(a)
Accrufer 30 mg, oral, 2 times daily buspirone (BUSPAR) 30 mg, 2 times daily diazePAM (VALIUM) 5 mg, As needed estradioL (CLIMARA) 0.025 mg/24 hr transdermal patch 1 patch ezetimibe (ZETIA) 10 mg, oral, Daily FLUoxetine (PROZAC) 20 mg, Dail
Cephalexin, Ciprofloxacin
XR shoulder 2+ views right Order: (withheld) Narrative X-rays of the right shoulder demonstrate concentrically reduced glenohumeral joint centered on axillary view no acute bony abnormality noted